India's Concord Biotech rises after board to consider bonus share issue
BUZZ-India's Concord Biotech rises after board to consider bonus share issue ** Shares of pharmaceutical company Concord Biotech CONB.NS up 4.6% at 1,562.40 rupees, highest level in over three weeks
** Stock marks biggest pct jump since July 31, 2026
** Company's board to consider proposal for issuance of bonus equity shares to existing shareholders
** Proposal to be considered at board meeting on September 23
** YTD, shares up 16.01%
(Reporting by Saikeerthi in Bengaluru)
((Saikeerthi@thomsonreuters.com; (+91) 8296756080))
Recent news on Concord Biotech
See all newsIndia's Concord Biotech rises after board to consider bonus share issue
Brief: Concord Biotech Ltd June-Quarter Consol Net Profit 585.3 Million Rupees
Brief: Concord Biotech Completes PPB (Kenya) And NDA (Uganda) Inspection At Unit-Ii Formulation Facility
Brief: Concord Biotech Completes Anvisa Inspection At Limbasi API Manufacturing Facility
India's Concord Biotech jumps to 4-month high after US FDA drug approval